(Information sent by the signatory company)
-An industry-wide survey reveals that centralization of regulation is the number one priority for medical technology
Increasing need for visibility and speed drives shift to digital regulatory systems
BARCELONA, Spain, March 1, 2023 /PRNewswire/ — New research shows that most medtech organizations are taking steps to advance regulatory issues, according to the second annual Veeva MedTech Regulatory Benchmark Report. More than half of medtech companies say establishing a single source of regulatory information (62%) and implementing a global, centralized regulatory information management (RIM) system (51%) will be the top industry goal in the coming years. next two years. With regulatory information management modernization underway, industry leaders are uniting data, content and systems to improve information and time to market.
The data reveals increased attention to digital systems to harmonize operations on a global scale, with two in five companies already having selected digital regulation technology. This shift to RIM’s digital systems highlights the need for greater transparency and collaboration between regional teams to meet evolving regulatory and change management requirements.
The report reveals positive developments in regulatory affairs and opportunities for improvement, including:
“With new regulations and the increasing complexity of the supply chain, medtech companies are evaluating paths toward more seamless processes so that high-quality data can be shared across teams,” said Seth Goldenberg, vice president of Veeva MedTech. . “This research shows that the medtech industry is making progress by advancing regulatory operations for better global visibility, data accuracy, and compliance.”
The Veeva MedTech Regulatory Benchmark Report examines the diagnostics and medical device industry’s progress toward modernizing regulatory operations. Respondents included regulatory affairs professionals from more than 100 medtech organizations around the world, from enterprises to midsize companies. Check out the comprehensive annual study exploring how medtech companies manage global visibility and compliance, speed to market, post-market compliance, and modernization.
About Veeva Systems Veeva (NYSE: VEEV) is the world leader in cloud software for the life sciences industry. Committed to innovation, product excellence and customer success, Veeva serves more than 1,000 customers, from the world’s largest pharmaceutical companies to emerging biotech companies. As a Public Benefit Corporation, Veeva is committed to balancing the interests of all stakeholders, including customers, employees, shareholders, and the industries it serves. For more information, visit veeva.com/eu.
Photo – https://mma.prnewswire.com/media/2011266…Logo – https://mma.prnewswire.com/media/1488285…
View original content: https://www.prnewswire.com/news-releases/la-centralizacion-de-la-regulacion-es-la-prioridad-numero-uno-para-la-tecnologia-medica-301758904.html
